Janus Henderson Group’s Xenon Pharmaceuticals XENE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$243M	Buy	4,175,982 +91,948	+2%	+$4.24M	0.12%	174
2025 Q4	$183M	Buy	4,084,034 +140,149	+4%	+$5.89M	0.08%	204
2025 Q3	$158M	Buy	3,943,885 +366,150	+10%	+$12.9M	0.07%	216
2025 Q2	$112M	Buy	3,577,735 +252,642	+8%	+$8.24M	0.05%	250
2025 Q1	$114M	Buy	3,325,093 +458,338	+16%	+$17.4M	0.06%	247
2024 Q4	$112M	Buy	2,866,755 +314,363	+12%	+$13M	0.06%	263
2024 Q3	$101M	Buy	2,552,392 +1,507,135	+144%	+$60.8M	0.05%	279
2024 Q2	$40.8M	Buy	1,045,257 +103,688	+11%	+$4.14M	0.02%	425
2024 Q1	$40.5M	Sell	941,569 -24,496	-3%	-$1.13M	0.02%	431
2023 Q4	$44.5M	Buy	966,065 +583,760	+153%	+$20.6M	0.03%	402
2023 Q3	$13.1M	Buy	382,305 +54,961	+17%	+$2.06M	0.01%	612
2023 Q2	$12.6M	Buy	327,344 +5,879	+2%	+$234K	0.01%	651
2023 Q1	$11.5M	Buy	321,465 +29,679	+10%	+$1.1M	0.01%	683
2022 Q4	$11.5M	Sell	291,786 -175,882	-38%	-$6.4M	0.01%	691
2022 Q3	$16.9M	Buy	467,668 +190,994	+69%	+$6.87M	0.01%	709
2022 Q2	$8.41M	Buy	276,674 +266,393	+2,591%	+$8.06M	0.01%	731
2022 Q1	$315K	Buy	+10,281	New	+$308K	﹤0.01%	2188